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Summary 
Activation of an immune response requires intercellular contact between T lymphocytes and antigen- 
presenting cells (APC). Interaction of the T cell antigen receptor (TCK) with antigen in the 
context of major histocompatibility molecules mediates signal transduction, but T cell activation 
appears to require the induction of a second costimulatory signal transduction pathway. Recent 
studies suggest that interaction of CD28 with B7 on APC might deliver such a costimulatory 
signal. To investigate the role of CD28 signal transduction during APC-dependent T cell activation, 
we have used Staphylococcal enterotoxins (SEs) presented by a B7-positive APC. We used anti- 
B7 monoclonal antibodies and a mutant interleukin 2 (II.-2) promoter construct, unresponsive 
to CD28-generated signals, in transient transfection assays to examine the contribution of the 
CD28-B7 interaction to II.-2 gene activation. These studies indicate that the CD28-regnlated 
signal transduction pathway is activated during SE stimulation of T cells and plays an important 
role in SE induction of I1.-2 gene expression  through its influence upon the CD28-responsive 
element contained within the IL-2 gene promoter. This effect is particularly profound in the 
activation of the IL-2 gene in peripheral blood T  cells. 
T  lymphocytes are activated by antigen to initiate immune 
responses during a complex interaction with APC. The 
specificity of the T cell response is determined by the TCK, 
but interactions with other T cell surface molecules are re- 
quired for activation (1, 2). It is believed that the TCK delivers 
one set of signals, and another receptor delivers a second signal 
that is required for T cell activation. One candidate for the 
receptor that mediates this second signal is CD28. Treatment 
of T  cells with mAb directed against  CD28  induces an 
unidentified but distinct signal transduction pathway that syn- 
ergizes with TCR-generated signals to increase mKNA level 
and secretion of several T cell lymphokines, including IL-2, 
GM-CSF, IFN-% I1.-3, TNF-ot, and lymphotoxin (3). CD28 
signal transduction increases both the rate of IL-2 transcrip- 
tion by activating a specific element of the IL-2 promoter, 
and the stability of the IL-2 mRNA (4,  5). 
A ligand for CD28, B7, has recently been identified (6). 
B7 was first identified on activated B cells and, like CD28, 
is a member of the Ig superfamily (7). Recent studies indi- 
cate that either B7-Ig C3'1 fusion proteins, or B7-transfected 
Chinese hamster ovary cells, can increase proliferation and 
I1.-2 expression from suboptimally activated CD28 + T cells 
(8, 9). These studies suggest that the interaction of CD28 
with B7 can generate a costimulatory signal capable of am- 
plifying T  cell lymphokine expression. 
To investigate the role of CD28 signal transduction during 
APC-dependent activation of the Ib2 gene, we have utilized 
Staphylococcal enterotoxins (SEs) presented by a B7-positive 
APC as a model system. SE's activate T cells by interacting 
with specific variable (V) regions of the TCK/3 chains (10). 
The SEs bind to class II MHC molecules and require the pres- 
ence of class II MHC for efficient activation of T cells (10). 
Using anti-B7 mAbs and a mutant II..2 promoter that is largely 
unresponsive to CD28-generated signals, we have examined 
the contribution of CD28 signal transduction to IL-2 gene 
activation. Our findings indicate that the CD28-regulated 
signal transduction pathway is activated and plays an impor- 
tant role in APC-dependent SE induction of IL-2 gene ex- 
pression. 
Materials and Methods 
Cells.  The human leukemic T cell line Jurkat was maintained 
as described (11). Nonadherent PBLs were isolated by density- 
gradient centrifugation through Ficoll-Hypaque  (Pharmacia Fine 
Chemicals, Piscataway, NJ) followed  by plastic absorption for 2 h 
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10% FCS, penicillin G, streptomycin (Irvine Scientific,  Santa Ana, 
CA), and PHA (100 ng/ml, Burroughs Wellcome, Research Tri- 
angle Park, NC) for 48 h before transfection. 
Immunoprecipitations and Western Blots.  Immunoprecipitates of 
TCR ~ were isolated and resolved  on 15% SDS-PAGE gels, trans- 
ferred to nitrocellulose, and analyzed for the presence of phos- 
photyrosine or TCR ~ as described (11). 
Inositol Phosphate Assays.  Jurkat cells were loaded with [3H]myo- 
inositol as described (11). The Jurkat ceUs were mixed with either 
mAb anti-Leu4 (1/1,000 dilution of ascites), an equal number of 
Raji cells alone, or Raji ceUs and 100 ng/ml SED (Toxin  Technology, 
Madison, WI), and the cells were pelleted to promote call-cell con- 
tact. The cells were cultured for the indicated period of time at 
37~  in the presence of 10 mM LiC1  and then lysed. Soluble ino- 
sitol  phosphate generation  was  determined,  as  previously de- 
scribed (11). 
Transfections.  Jurkat cells were transiently transfected with ei- 
ther plb2-Luc  or pM2-Luc using DEAE-Dextran, as previously 
described (12). PBMCs were transfected using electroporation as 
described (13). Transfection  ef~ciency  was equalized  by cotransfecting 
with RSV-CAT. 
Luciferase and Chloramphenicol Acetyltransferase  Assays.  The de- 
termination of  luciferase  and chloramphenicol  acetyltransferase  ac- 
tivity was performed as described (12). 
Results  and  Discussion 
Since there have been conflicting reports regarding the signal 
transduction mechanisms by which "superantigens'~  such as 
the SEs stimulate T  cell activation (14, 15), we attempted 
to characterize the TCtL-generated signal transduction events 
after SE stimulation. The enterotoxin SED, when presented 
by the class II-positive B cell lymphoblastoid line Raji, acti- 
Figure 1.  The presentation  of SE by an APC induces  TCR-regulated 
tyrosine  kinase  activation.  Immunoprecipitation  and Western  blotting of 
the TCR ~ chain.  Jurkat cells were incubated  with medium  (lane 1), 100 
ng/ml SED alone (lane 2), Raji calls alone (lane 3), Raji cells, and 100 
ng/ml SED (lanes 4-7), or with the anti-TCg mAb C305 (lane 8) for 
the indicated  times.  Immunoprecipitates  of  the TCR ~ chain  were  isolated 
and analyzed  by Western  blot for phosphotyrosine  (A) or TCR ~ (B). 
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Figure 2.  SE presentation  induces  inositol  phosphate  generation.  Time 
course of total soluble  inositol  phosphates  generation  in response  to incu- 
bation with Raji  alone  (A), anti-TCR  mAb C305 (R), or Raji  and 100 
ng/ml  SED (D). Data  points  represent  the mean _+ SD of  triplicate  samples. 
vates  the V38-expressing  T  cell line Jurkat  to secrete  IL2 
(16). To determine whether SE-induced IL-2 expression  in- 
volves a TCR-activated tyrosine kinase, we stimulated  Jurkat 
cells with SED and immunoprecipitated the TCR ~ chain. 
Exposure of  Jurkat cells to either Raji or SED cells alone did 
not significantly affect the phosphorylation state of the ~ chain, 
but stimulation with SED plus Raft cells induced rapid and 
prolonged phosphorylation of ~, comparable to that induced 
by anti-TCR mAb (Fig.  1). 
To investigate whether SED presented by Raft would also 
induce phospholipase C activity, we examined changes in ino- 
sitol phosphate levels after incubation with either Raji cells 
alone, Raji cells coated with SED, or with anti-TCR mAbs 
(Fig. 2). Treatment of Jurkat cells with anti-TCR antibody 
induced a sixfold increase in the level of total inositol phos- 
phates. Whereas incubation with Raji alone failed to induce 
a detectable increase  in inositol phosphates, Raji plus SED 
induced a 17-fold increase over that seen in unstimulated  Jurkat 
after 30 min. By these criteria at least, activation of T  cells 
by SE on an APC induces TCIL-generated signals  qualita- 
tively similar to that induced by nominal antigen or anti- 
TCK mAbs. 
To determine if interaction of CD28 with B7 is involved 
in the induction of Iio-2 secretion during SED presentation 
to Jurkat, we attempted to block binding of CD28  to B7 
using mAbs directed to B7. Addition of either of two different 
mAbs to B7 decreased  the SED-induced IL-2 secretion by 
58-68%  (data not shown). 
CD28 stimulation induces the binding of a nuclear com- 
plex, CD28KC, to an element in the 5' flanking region of 
the IL-2 promoter that is responsible for most of the CD28- 
induced IL2 promoter  activity (4).  To  ascertain  whether 
CD28KC activity was induced during SE stimulation, Jurkat 
cells were transfected with either the plL-2-Luc  construct, 
which contains sequences from -326 to  + 46 of the human 
Ib2 gene directing transcription of the firefly luciferase gene, 
or the pM2-Luc construct, which also includes the  -326 
to  +46 region of the human II.-2 gene, but contains a 4-bp 
substitution in the CD28RE site at  -159 to  -156 (4). The 
pM2-Luc construct responds to either phorbol 12-myristate 
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Figure 3.  The CD28 response  element  is involved  in SED-induced  acti- 
vation of the Ib2 gene promoter.  Jurkat cells were transiently  transfected 
with either the plb2-Luc (filled bars) or the pM2-Luc  plasmids (open bars). 
After 40 h, the transfected  Jurkat cells were incubated with Raji alone, 
Raji and 100 ng/ml SED, or Raji cells, 100 ng/ml SED, and mAb B7 
(1:500 dilution of ascites). Data for the pM2-Luc-transfected  cells are 
presented as the percent Raft  plus SED-induced  response of the wild-type 
plL2-Luc (mean of 1,118 light U/10 #g). Results  represent the mean +_ 
SD of triplicate samples from three independent experiments. 
13-acetate  (PMA) and ionomycin treatment, or anti-TCP,.- 
generated signals, as well as the wild-type plL-2-Luc construct, 
however, CD28-induced activity is decreased by 80-90% (4). 
In Jurkat cells transfected with plL-2-Luc, incubation with 
Raji cells and SED induced a 15-25-fold increase in luciferase 
activity compared with cells incubated with Raji alone (Fig. 
3).  In contrast, Jurkat transfected with the pM2-Luc con- 
struct responded only 41% as well. Addition of anti-B7 mAb 
caused a 62% decrease in the activity induced in the plL-2- 
Luc transfected cells, but only minimally affected the SED- 
induced luciferase activity from the pM2-Luc-transfected  cells, 
indicating that the B7 antibody treatment and the enhancer 
mutation were both influencing the same pathway. 
To  determine  whether  CD28  signal  transduction  also 
affected I1.-2 transcription in peripheral blood T cells, PBLs 
were transfected with either the plL-2-Luc or the pM2-Luc 
constructs,  and  stimulated  with  combinations  of PMA, 
ionomycin, anti-TCR, and anti-CD28. As seen in the Jurkat 
T  cell line, treatment with PMA and ionomycin, or with 
PMA and anti-TCR mAb induced similar levels of luciferase 
activity from either construct (Fig. 4 A). Addition of anti- 
CD28 mAb to PMA and ionomycin-treated cells increased 
the induced luciferase activity by 4.2-fold in the plL2-Luc- 
transfected cells. However, the anti-CD28 treatment only in- 
duced a 1.6-fold  increase in the pM2-Luc transfected cells, 
19% of the observed  increase for the plL-2-Luc-transfected 
cells. Moreover, treatment of pM2-Luc-transfected cells with 
PMA and anti-CD28 mAb induced only 14% of the luciferase 
activity elicited from lymphocytes transfected with the wild- 
type pll~2-Luc plasmid. Thus, the comparison of the activity 
of the wild-type plL-2-Luc to the activity of pM2-Luc con- 
taining the 4-bp mutation of the CD28 responsive  element 
reveals  a  specific  target  of the  CD28  signal transduction 
pathway in normal T cells, as was previously detected in Jurkat. 
Activation of normal peripheral T  lymphocytes is strin- 
gently regulated, perhaps more so than might be observed 
with the leukemic T  cell line such as Jurkat. To assess the 
role of CD28  signal transduction in APC-de~endent SE- 
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Figure 4.  CD28  stimulation  increases II.-2 promoter activity  in peripheral blood T cells, and the CD28 signal transduction  pathway  is used during 
SE-induced IL-2 gene activation. Peripheral blood T cells were transfected  with either the plD2-Luc (filled bars) or the pM2-Luc  plasmids (open Mrs). 
(,4) The transfected  T cells were stimulated  with the indicated  combinations  of PMA (5 ng/ml), ionomycin  (1 #M), anti-CD3 (anti-Leu  4, 100 ng/ml), 
and anti-CD28 (9.3, 100 ng/ml). The results are presented as the percent response of the PMA- and ionomycin-induced  plL-2-Luc-transfected  cells 
(mean of 12,178 light U/10 #g). (B) The transfected  T cells were incubated with Raji cells and 100 ng/ml each SED, TSST, and SEC2 (Group 1), 
Raji, and 100 ng/ml each of SEA, SEB, and SEC3 (Group 2), or Raji and 100 ng/ml each of SEA, SEB, and SEE (Group 3) for 8 h. Anti-B7 antibody 
was used at a 1:500 dilution  of ascites. Data for the pM2-Luc-transfected  cells are presented as the percent response of the wild-type  plL-2-Luc  (mean 
of 6,207 light U/10 #g). Results represent the mean _+  SD of triplicate samples. 
1133  Fraser  et al.  Brief  Definitive Report induced activation of peripheral T  cells, mononuclear cells 
transfected with either the plL-2-Luc or the pM2-Luc con- 
structs were stimulated by SE presented on Raji cells. Com- 
binations of SEs were used to stimulate large numbers of T 
cells contained within the polyclonal T cell population. The 
SE-induced luciferase activity from the plL-2-Luc transfected 
lymphocytes ranged from 8 to 26-fold greater than the basal 
activity. In contrast, SE-induced activity in the pM2-Luc- 
transfected T cells was only 11-18% of that of the plL-2-Luc- 
transfected cells (Fig.  4 B). Moreover, the addition of anti- 
B7 antibody caused a 66% decrease in the luciferase activity 
of the plL-2-Luc-transfected  cells, but without significantly 
affecting the activity of the pM2-Luc-transfected cells. 
These studies indicate that B7 on the surface of an APC 
can activate CD28 signal transduction and that this pathway 
contributes substantially to the induction of IL-2 expression 
in the context of TCR signal transduction. This effect was 
particularly pronounced in peripheral T cells induced by SE 
stimulation. This supports the notion that antigen-induced 
IL-2 gene expression  is coordinately regulated by TCR- and 
CD28-generated signals  that activate  distinct transcription 
elements. Studies on murine T cell clones indicate that antigen- 
induced proliferation requires activation of a signal transduc- 
tion pathway in addition to those activated via the TCR (1). 
In the absence of this second,  or costimulatory signal, the 
T cells fail to secrete IL-2 and enter a prolonged nonrespon- 
sive or anergic state.  Whereas the current  studies do not 
directly address the role of the CD28 signal transduction in 
preventing induction of the anergic state, they indicate that 
CD28 signal transduction plays an important role in IL-2 gene 
activation and may act as this requisite costimulatory pathway. 
We thank Dr. L. M. Nadler for providing the B7 mAb and Dr. E. A. Clark for providing mAbs LB-1 
and BB-1. We also thank A. C. Chan and D. M. Desai for critically reading this manuscript. 
Address correspondence to Dr. James D. Fraser, School of Medicine, Division of Rheumatology/Immu- 
nology, University of California, San Francisco, U426, Box 0724, 3rd and Parnassus Avenues, San Fran- 
cisco, CA 94143-0724. 
Received for publication  18 October 1991 and in revised form  7January  1992. 
References 
1.  Schwartz, R,.H. 1990. A cell culture model for T lymphocyte 
clonal anergy. Science (Wash. DC). 248:1349. 
2.  Springer,  T.A. 1990. Adhesion  receptors of the immune system. 
Nature (Lond.). 346:425. 
3.  Thompson, C.B., T. Lindsten, J.A. Ledbetter, S.L. Kunkel, 
H.A. Young, S.G. Emerson,  J.M. Leiden,  and C.H. June. 1989. 
CD28 activation  pathway regulates the production of multiple 
T-cell-derived lymphokines/cytokines. Proc. Natl.  Acad. Sci. 
USA.  86:1333. 
4.  Fraser,  J.D., B.A. Irving, G.R. Crabtree, and A. Weiss. 1991. 
Regulation of interleukin-2 gene enhancer activity by the T 
cell accessory molecule CD28. Science (Wash. DC).  251:313. 
5.  Lindsten, T., C.H. June, J.A. Ledbetter, G. Stella, and C.B. 
Thompson. 1989. Regulation of  lymphokine messenger  RNA 
stability  by a surface-mediated  T cell activation  pathway.  Science 
(Wash. DC). 244:339. 
6.  Linsley,  P.S., E.A. Clark, and J.A. Ledbetter. 1990. T-cell an- 
tigen CD28 mediates  adhesion  with B cells  by interacting with 
activation antigen B7/BB1. Proa Natl. Acad. Sci. USA. 87:5031. 
7.  Freeman, G.J.,  A.S. Freedman, J.M.  Segil, G.  Lee, J.F. 
Whitman, and L.M. Nadler. 1989. B7, a new member of the 
Ig superfamily with unique expression on activated and neo- 
plastic B cells,  j. Immunol. 143:2714. 
8.  Linsley,  P.S., W. Brady,  L. Grosmaire,  A. Aruffo, N.K. Damle, 
and J.A. Ledbetter. 1991. Binding of the B cell activation an- 
tigen B7 to CD28 costimulates T cell proliferation and inter- 
leukin 2 mP~NA accumulation. J. Exp. Med, 173:721. 
9.  Gimmi, C.D., G.J. Freeman, J.G. Gribben, K. Sugita, A.S. 
Freedman, C. Morimoto, and L.M. Nadler. 1991. B-cell an- 
tigen B7 provides a costimulatory signal that induces T cells 
to proliferate and secrete interleukin 2. Proc. Natl. Acad. Sci. 
USA.  88:6575. 
10.  Marrack, P., and J.  Kappler. 1990. The Staphylococcal en- 
terotoxins and their relatives. Science (Wash. DC). 248:705. 
11.  Irving, B.A., and A. Weiss. 1991. The cytoplasmic  domain of 
the T cell receptor ~ chain is sufficient to couple to receptor- 
associated signal transduction pathways. Cell. 64:891. 
12.  Durand, D.R., J.-P. Shaw, M.R. Bush, R.E. Replogle, R. 
Gelagaje, and G.R. Crabtree. 1988. Characterization of an- 
tigen receptor response elements within the interleukin-2 en- 
hancer. Mol. Cell. Biol. 8:1715. 
13.  Cann, A.J., Y. Koyanagi,  and I.S.Y. Chen. 1988. High efficiency 
transfection  of  primary human lymphocytes  and studies of  gene 
expression. Oncogene. 3:123. 
14.  Chatila, T., N. Wood,  J. Parsonnet,  and R.S. Geha. 1988. Toxic 
shock syndrome toxin-1 induces inositol phospholipid turn- 
over, protein kinase C translocation, and calcium mobilization 
in human T cells,  j. Immunol. 140:1250. 
15.  O'Rourke, A.M., M.F. Mescher, and S.R. Webb. 1990. Acti- 
vation of polyphosphoinositide hydrolysis  by H-2 alloantigen 
but not MLS determinants. Science (Wash. DC). 249:171. 
16.  Herman, A., G. Croteau, R.-P. Sekaly,  J. Kappler, and P. Mar- 
rack. 1990. HLA-DR alleles differ in their ability to present 
staphylococcal  enterotoxins to T cells.  J. Exp. Med. 172:709. 
1134  CD28  and TCR Coordinately  Regulate Interleukin 2 Gene Expression 